Traduction de «double blind » (Néerlandais → Français) :

TERMINOLOGIE

postoperatief blinde-lissyndroom [blind loop syndrome]
Syndrome post-chirurgical de l'anse borgne

congenitaal | blinde-lissyndroom [blind loop syndrome] | congenitaal | darmdivertikel | congenitaal | diverticulitis van colon | dolichocolon | megaloappendix | megaloduodenum | microcolon | transpositie van | appendix | transpositie van | colon | transpositie van | darm
Diverticule congénital de l'intestin Diverticulite congénitale du côlon Dolichocôlon Méga-appendice Mégaduodénum Microcôlon Syndrome de l'anse borgne, congénital Transposition de:appendice | côlon | intestin

infectie door Onchocerca volvulus | onchocercosis | river blindness
Cécité des rivières Infection à Onchocerca volvulus

concentrische gezichtsveldbeperking | hemianopsie (heteroniem)(homoniem) | kwadrantanopsie | scotoom | arcuatum | scotoom | centraal | scotoom | ringvormig | scotoom | Bjerrum | vergrote blinde-vlek
Anopsie d'un quadrant Elargissement de la tache aveugle Hémianopsie (hétéronyme) (homonyme) Rétrécissement généralisé du champ visuel Scotome (de):annulaire | arciforme | Bjerrum | central

blind loop syndrome NNO
Syndrome de l'anse borgne SAI

doof blind hypopigmentatie syndroom, Yemenite-type
syndrome de Warburg-Thomsen

blinde vlek van oog
disque optique

blind of slechtziend aan beide ogen
aveugle ou malvoyant dans les deux yeux

blind-loop-syndroom
syndrome de l'anse borgne

blinde-lissyndroom
Syndrome de l'anse borgne

TRADUCTIONS EN CONTEXTE

Table 2: Search for additional RCTs Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for RCT’s Date 27/04/2010 Keywords Breast neoplasms (MESH), mass screening (or early detection) (MESH), mammography (MESH) Medline 1 Randomized controlled trials/ (66083) Medline (OVID): (OVID): 2 Randomized controlled trial.pt (289038) Filter Filter 3 Random allocation/ (67885) RCT RCT 4 Double blind method/ (105956) 5 Single blind method/ (13834) 6 Clinical trial.pt (460563) 7 exp clinical trial/ (606505) 8 or/1-7 (718664) 9 (clinic$ adj trial$).tw (146686) 10 ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw (105209) 11 Placebos/ (28712) 12 Placebo$.tw (125428) 13 Randomly allocated.tw (12231) 14 (allocated adj2 random).tw (654) 15 9 or 10 or 11 or 12 or 13 or 14 (312732) 16 8 or 15 (842155) 17 Case report.tw (155883) 18 Letter.pt (688664) 19 Historical article.pt (263287) 20 Review of reported cases.pt (0) 21 Review,multicase.pt (0) 22 17 or 18 or 19 or 20 or 21 (1098644) 23 16 not 22 (822810) 24 Breast/ or Breast Diseases/ (30717) 25 Neoplasms/ (216644) 26 24 and 25 (535) 27 (breast$ adj5 neoplasm$).tw (1588) 28 (breast$ adj5 cancer$).tw (135654) 29 (breast$ adj5 carcin$).tw (31778) 30 (breast$ adj5 tumo$).tw (23438) 31 (breast$ adj5 metasta$).tw (16580) 32 (breast$ adj5 malig$).tw (7361) 33 exp Breast Neoplasms/ (171606) 34 exp Carcinoma, Ductal, Breast/ (8460) 35 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (207174) 36 mammography.mp (23598) 37 screening.mp (274211) 38 36 or 37 (288429) 39 23 and 35 and 38 (2326) 40 limit 39 to (yr=" 2008 -Current" and " all adult (19 plus years)" and (dutch or english or french)) (241) 41 from 40 keep 1-241 (241) 42 from 41 keep 1-241 (241) CENTRAL Breast neoplasms (MESH) and early detection (MESH) or 61 mammography (MESH) (manual limit 2008-2010) in title , abstracts or key words
Table 4: Search for additional RCTs Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for RCT’s Date 27/04/2010 Keywords Breast neoplasms (MESH), mass screening (or early detection) (MESH), mammography (MESH) Medline 1 Randomized controlled trials/ (66083) Medline (OVID): (OVID): 2 Randomized controlled trial.pt (289038) Filter Filter 3 Random allocation/ (67885) RCT RCT 4 Double blind method/ (105956) 5 Single blind method/ (13834) 6 Clinical trial.pt (460563) 7 exp clinical trial/ (606505) 8 or/1-7 (718664) 9 (clinic$ adj trial$).tw (146686) 10 ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw (105209) 11 Placebos/ (28712) 12 Placebo$.tw (125428) 13 Randomly allocated.tw (12231) 14 (allocated adj2 random).tw (654) 15 9 or 10 or 11 or 12 or 13 or 14 (312732) 16 8 or 15 (842155) 17 Case report.tw (155883) 18 Letter.pt (688664) 19 Historical article.pt (263287) 20 Review of reported cases.pt (0) 21 Review,multicase.pt (0) 22 17 or 18 or 19 or 20 or 21 (1098644) 23 16 not 22 (822810) 24 Breast/ or Breast Diseases/ (30717) 25 Neoplasms/ (216644) 26 24 and 25 (535) 27 (breast$ adj5 neoplasm$).tw (1588) 28 (breast$ adj5 cancer$).tw (135654) 29 (breast$ adj5 carcin$).tw (31778) 30 (breast$ adj5 tumo$).tw (23438) 31 (breast$ adj5 metasta$).tw (16580) 32 (breast$ adj5 malig$).tw (7361) 33 exp Breast Neoplasms/ (171606) 34 exp Carcinoma, Ductal, Breast/ (8460) 35 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (207174) 36 mammography.mp (23598) 37 screening.mp (274211) 38 36 or 37 (288429) 39 23 and 35 and 38 (2326) 40 limit 39 to (yr=" 2008 -Current" and " all adult (19 plus years)" and (dutch or english or french)) (241) 41 from 40 keep 1-241 (241) 42 from 41 keep 1-241 (241) CENTRAL Breast neoplasms (MESH) and early detection (MESH) or 61 mammography (MESH) (manual limit 2008-2010) in title , abstracts or key words

controlled trial without randomization double blind double blind randomised placebo controlled trial economic evaluation evaluation guidelines
case series cross-sectional study controlled trial without randomization double blind double blind randomised placebo controlled trial economic evaluation evaluation guidelines

- Paavonen J, Jenkins D, Bosch FX, Naud P, Salméron J, C. Wheeler et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women : an interim analysis of a phase III double-blind, randomised controlled trial.
- Paavonen J, Jenkins D, Bosch FX, Naud P, Salméron J, C. Wheeler et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

Lederle F, Busch D, Mattox K et al. Cost-effective treatment in the elderly. A randomized double-blind comparison of sorbitol and lactulose.
A randomized double-blind comparison of sorbitol and lactulose.

Hickson M, D’Souza A, Muthu N. et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial.
Butler CC, Duncan D, Hood K. Does taking probiotics routinely with antibiotics prevent antibiotic associated diarrhoea?

Amland P.F., Andenaes K., Samdal F., Lingaas E., Sandsmark M., Abyholm F., Giercksky K.E. A prospective, double-blind, placebo-controlled trial of a single dose of azithromycin on postoperative wound infection in plastic surgery.
Amland P.F., Andenaes K., Samdal F., Lingaas E., Sandemark M., Abyholm F., Giercksy K.E.. A prospective, double-blind, placebo-controlled trial of a single dose of azithromycin on postoperative wound infection in plastic surgery.

M. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography : a randomized, double-blind, placebo-controlled study.
Byl B., Deviere J., Struelens M.J., Roucloux I. , De Coninck A., Thys J.P., and Cremer M. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study.

41. Tonnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
41. Tonnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of Bupropion SR for smoking cessation.

Rosenstock J, Tuchman M, LaMoreaux L en Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
Rosenstock J, Tuchman M, LaMoreaux L et Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial .

Deze publicatie is het onderwerp geweest van talrijk commentaar (3) , zoals het benadrukken dat de meta-analyse, studies inhield waarbij een niet adequate of onduidelijke methode van " double blind test" gevolgd werd en dat men niet verklaart waarom een gekende klinische proef, over een grote groep patiënten, ontbreekt.
Cette publication a fait l’objet de nombreux commentaires (3) , notamment l’inclusion dans la métaanalyse d’études dont la méthode de " mise en double insu" est inadéquate ou peu claire, ainsi que l’absence inexpliquée d’un essai clinique connu portant sur de nombreux patients.